Product image of Medopenem (Meropenem Anhydrous) supplied by GNH India

Medopenem

Active Ingredient:
Meropenem Anhydrous
Origin:
EU

Medopenem (Meropenem Anhydrous)

Meropenem, the active ingredient in Medopenem, is a carbapenem antibiotic presented as an intravenous formulation for hospital use. It is employed to treat severe bacterial infections, including complicated intra‑abdominal infections, complicated urinary tract infections, skin and soft‑tissue infections, meningitis, and severe sepsis in adult patients.

GNH India supplies Medopenem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and procurement teams worldwide, with established quality‑assured manufacturing and distribution processes. Our network ensures timely delivery, regulatory compliance and support for clinical use across diverse healthcare settings.

Manufacturer / TM Owner

Medochemie Hellas Sa

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Medopenem (meropenem) is a carbapenem antibiotic used to treat serious bacterial infections.

  • Complicated intra‑abdominal infections: Provides broad‑spectrum coverage to eradicate Gram‑negative, Gram‑positive and anaerobic pathogens within the abdominal cavity.
  • Complicated urinary tract infections: Eliminates resistant uropathogens causing upper and lower urinary tract disease.
  • Skin and soft tissue infections: Targets mixed flora in severe cellulitis, necrotizing fasciitis and postoperative wound infections.
  • Meningitis: Achieves therapeutic concentrations in cerebrospinal fluid to treat bacterial meningitis.
  • Severe sepsis: Offers rapid bactericidal activity against multidrug‑resistant organisms in systemic infection.

How It Works

  • Meropenem binds to penicillin‑binding proteins on bacterial cell walls, inhibiting the final transpeptidation step of peptidoglycan synthesis. This disruption weakens the cell wall, leading to osmotic instability and bacterial lysis. The drug displays high affinity for a broad range of PBPs, providing activity against many Gram‑negative, Gram‑positive and anaerobic organisms, including those resistant to other β‑lactams.

Side Effects

Common Side Effects

  • Diarrhea: mild to moderate loose stools.
  • Nausea: occasional feeling of queasiness.
  • Vomiting: occasional emesis.
  • Rash: transient skin erythema.
  • Headache: mild to moderate intensity.
  • Elevated liver enzymes: transient increase in transaminases.

Serious or Rare Side Effects

  • Seizures: especially in patients with CNS disorders or high doses.
  • Clostridioides difficile colitis: severe diarrhea due to gut flora disruption.
  • Anaphylaxis: acute, potentially life‑threatening allergic reaction.
  • Severe allergic reactions: including Stevens‑Johnson syndrome.
  • Renal impairment: acute kidney injury in susceptible individuals.
  • Thrombocytopenia: low platelet count leading to bleeding risk.

Precautions & Warnings

Medopenem should be used with caution in specific clinical situations.

  • Renal function: adjust dose in patients with impaired renal clearance.
  • Allergy: avoid in individuals with known hypersensitivity to carbapenems or other β‑lactam antibiotics.
  • Seizure risk: monitor patients with pre‑existing CNS disorders or receiving high‑dose therapy.
  • Pregnancy: use only if the potential benefit justifies the potential risk to the fetus; safety data are limited.
  • Drug interactions: review concomitant medications that may lower seizure threshold.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Avoid Interactions

Medopenem may interact with other medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid)

  • Valproic acid: meropenem reduces serum valproate levels, risking seizure breakthrough.
  • Probenecid: may increase meropenem plasma concentrations, enhancing toxicity.
  • High‑dose carbapenems with CNS‑active drugs: can potentiate seizure risk.

Moderate Interactions (Monitor Closely)

  • Loop diuretics: combined nephrotoxic potential warrants renal function monitoring.
  • NSAIDs: may increase risk of renal impairment when used together.
  • Anticoagulants: monitor INR or PT as meropenem can affect coagulation parameters.

Frequently Asked Questions

Medopenem contains meropenem, a carbapenem antibiotic indicated for the treatment of serious bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, severe skin and soft‑tissue infections, bacterial meningitis and severe sepsis in hospitalized patients.

Meropenem inhibits bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, preventing the cross‑linking of peptidoglycan strands. This leads to loss of cell‑wall integrity, osmotic instability and rapid bacterial lysis, providing broad‑spectrum bactericidal activity against many resistant organisms.

The dosage of Medopenem is individualized by the prescribing clinician based on the type and severity of infection, patient weight, renal function and local antimicrobial guidelines. No fixed regimen is provided here; the prescriber determines the appropriate dose and infusion rate.

Safety data for meropenem in pregnancy and lactation are limited. It is classified as pregnancy category unknown, and use is recommended only when the potential benefit to the mother outweighs any possible risk to the fetus. Breastfeeding mothers should consult their healthcare provider before use.

To order Medopenet, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any required import documentation.

The primary alternative to meropenem is imipenem/cilastatin, another carbapenem. Both offer broad‑spectrum coverage, but meropenem is generally considered more stable against renal dehydropeptidase and may have a slightly broader activity against certain resistant Gram‑negative organisms. Choice depends on local resistance patterns, patient factors and clinician preference.

Medopenem for intravenous use should be stored at 2‑8 °C, protected from light, and must not be frozen. Once reconstituted, it should be used within the time frame specified in the product labeling and kept in the original container to maintain sterility.

Medopenem is administered by intravenous infusion. The reconstituted solution is diluted in an appropriate compatible fluid and infused over a period determined by the prescribing clinician, typically ranging from 15 minutes to 30 minutes, depending on the dose and patient condition.

The most serious adverse events associated with meropenem include seizures, especially in patients with pre‑existing CNS disorders or high‑dose therapy; severe allergic reactions such as anaphylaxis; and Clostridioides difficile‑associated colitis, which can cause life‑threatening diarrhea.

Medopenem is contraindicated in patients with a known hypersensitivity to meropenem, other carbapenems, or any β‑lactam antibiotics. Caution is also advised for individuals with a history of seizures, severe renal impairment without dose adjustment, or those who have experienced severe allergic reactions to related drugs.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Meropenem Anhydrous

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT